Tayebeh Oghabi Bakhshaiesh
Overview
Explore the profile of Tayebeh Oghabi Bakhshaiesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Damough S, Bayat E, Oghabi Bakhshaiesh T, Barkhordari F, Esmaeili R, Nematollahi L, et al.
Ann Med Surg (Lond)
. 2023 Sep;
85(9):4348-4354.
PMID: 37663730
Background: Breast cancer is one of the most frequent causes of cancer death in women. The application of immunotoxins to target overexpressed biomarkers on the surface of cancer cells and...
2.
Hasanvand Z, Oghabi Bakhshaiesh T, Peytam F, Firoozpour L, Hosseinzadeh E, Motahari R, et al.
Bioorg Chem
. 2023 Feb;
133:106383.
PMID: 36764231
Tyrosine protein kinases (TKs) have been proved to play substantial roles on many cellular processes and their overexpression tend to be found in various types of cancers. Therefore, over recent...
3.
Mohammadian E, Oghabi Bakhshaiesh T, Jouyban A, Nazeri E, Hasanvand Z, Moghimi S, et al.
Arch Pharm (Weinheim)
. 2022 Nov;
356(3):e2200349.
PMID: 36408898
An important role has been considered for the vascular endothelial growth factor receptor 2 (VEGFR-2) in the angiogenesis process, so that its inhibition is an important scientific way for cancer...
4.
Oghabi Bakhshaiesh T, Nazeri E, Jafarbeik-Iravani N, Shirvani-Farsani Z, Esmaeili R
Ann Med Surg (Lond)
. 2022 Sep;
80:104162.
PMID: 36045810
•BsmI and TaqI have association with breast cancer risk in Iranian women.•No significant associations were identified between the FokI and ApaI and breast cancer risk in Iranian women.•No association was...
5.
Motahari R, Boshagh M, Moghimi S, Peytam F, Hasanvand Z, Oghabi Bakhshaiesh T, et al.
Sci Rep
. 2022 Jun;
12(1):9683.
PMID: 35690595
The novel derivatives of tetrahydropyridothienopyrimidine-based compounds have been designed and efficiently synthesized with good yields through seven steps reaction. The anticancer activity of compounds 11a-y has been evaluated against MCF-7,...
6.
Oghabi Bakhshaiesh T, Esmaeili R
Cell Cycle
. 2022 Feb;
21(9):883-893.
PMID: 35108162
Radiotherapy has an essential role in breast cancer treatment. However, tumor cells may be resistant to radiotherapy. Noncoding RNAs are considered regulators of different pathways which modulate radiotherapy. This systematic...
7.
Esmaeili R, Darbandi-Azar A, Sadeghpour A, Majidzadeh-A K, Eini L, Jafarbeik-Iravani N, et al.
Am J Med Sci
. 2021 Feb;
361(6):765-775.
PMID: 33582157
Background: Stem cell therapy is among the novel approaches for the treatment of post-myocardial infarction cardiomyopathy. This study aims to compare the effect of stromal-derived factor 1 α (SDF1α), mesenchymal...
8.
Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh M, et al.
Eur J Med Chem
. 2021 Feb;
214:113228.
PMID: 33550180
No abstract available.
9.
Faraji A, Motahari R, Hasanvand Z, Oghabi Bakhshaiesh T, Toolabi M, Moghimi S, et al.
Bioorg Chem
. 2020 Dec;
108:104553.
PMID: 33376012
A series of quinazolin-4(3H)-one based agents containing thiadiazole-urea were designed, synthesized, and biologically evaluated. The proliferation rate of PC3 cells was moderately reduced by compound 9f (IC = 17.7 μM)which...
10.
Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh M, et al.
Eur J Med Chem
. 2020 Dec;
209:112942.
PMID: 33328104
Inhibition of angiogenesis is a promising strategy for the treatment of cancer. Herein, we describe the design and synthesis of thieno[2,3-d]pyrimidine-1,3,4-thiadiazole-aryl urea derivatives 11a-m to evaluate their efficacy in the...